dexmedetomidine has been researched along with Chemical and Drug Induced Liver Injury in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (90.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| He, XJ; Huang, S; Liu, MH; Xie, B | 1 |
| Chou, AH; Lee, HC; Liao, CC; Liou, JT; Liu, FC | 1 |
| Fan, H; Feng, X; Hu, X; Sha, J; Song, M; Wang, C; Zhang, H; Zhao, Y | 1 |
| Altinbas, A; Ayhan, S; Canakci, E; Kokturk, S; Noyan, T; Tas, N | 1 |
| Ao, J; He, L; Huang, Y; Li, X; Wang, A; Wang, C; Yang, C | 1 |
| Deveci, E; Doğan, E; Ece, A; Güzel, A; Kaplan, İ; Şen, HS; Sen, V; Söker, S; Uluca, U | 1 |
| Chen, JH; Jin, SY; Lei, DX; Song, XR; Yu, GF; Zhang, WH; Zhou, SL | 1 |
| Arpaci, H; Arslan, M; Comu, FM; Kavutcu, M; Kocabiyik, M; Ozturk, L; Sezen, SC; Turgut, HC | 1 |
1 review(s) available for dexmedetomidine and Chemical and Drug Induced Liver Injury
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
9 other study(ies) available for dexmedetomidine and Chemical and Drug Induced Liver Injury
| Article | Year |
|---|---|
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests | 2011 |
[Dexmedetomidine alleviates LPS/D-Gal-induced acute liver injury via up-regulation of LC3-II expression in mice].
Topics: Alanine Transaminase; Animals; Chemical and Drug Induced Liver Injury; Dexmedetomidine; Galactosamine; Interleukin-6; Lipopolysaccharides; Liver; Male; Mice; Mice, Inbred BALB C; Microtubule-Associated Proteins; Tumor Necrosis Factor-alpha; Up-Regulation | 2021 |
The MAP2K4/JNK/c-Jun Signaling Pathway Plays A Key Role In Dexmedetomidine Protection Against Acetaminophen-Induced Liver Toxicity.
Topics: Acetaminophen; Adrenergic alpha-2 Receptor Agonists; Animals; Chemical and Drug Induced Liver Injury; Dexmedetomidine; Dose-Response Relationship, Drug; JNK Mitogen-Activated Protein Kinases; Liver; Male; MAP Kinase Kinase 4; Mice; Mice, Inbred C57BL; Proto-Oncogene Proteins c-jun; Signal Transduction; Structure-Activity Relationship | 2019 |
Dexmedetomidine attenuates lipopolysaccharide-induced liver oxidative stress and cell apoptosis in rats by increasing GSK-3β/MKP-1/Nrf2 pathway activity via the α2 adrenergic receptor.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Chemical and Drug Induced Liver Injury; Cytoprotection; Dexmedetomidine; Disease Models, Animal; Dual Specificity Phosphatase 1; Glycogen Synthase Kinase 3 beta; Lipopolysaccharides; Liver; Male; NF-E2-Related Factor 2; Oxidative Stress; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Signal Transduction | 2019 |
Acute acetaminophene-induced hepatotoxicity and nephrotoxicity; therapeutic effect of dexmedetomidine.
Topics: Acetaminophen; Acetylcysteine; Animals; Antioxidants; Chemical and Drug Induced Liver Injury; Dexmedetomidine; Glutathione; Liver; Oxidative Stress; Rats | 2019 |
Dexmedetomidine alleviated lipopolysaccharide/D-galactosamine-induced acute liver injury in mice.
Topics: Animals; Chemical and Drug Induced Liver Injury; Dexmedetomidine; Galactosamine; Lipopolysaccharides; Liver; Male; MAP Kinase Kinase 4; Mice, Inbred BALB C; Protective Agents; Tumor Necrosis Factor-alpha | 2019 |
Preventive effects of dexmedetomidine on the liver in a rat model of acid-induced acute lung injury.
Topics: Animals; Antioxidants; Chemical and Drug Induced Liver Injury; Dexmedetomidine; Gene Expression Regulation; Humans; Hydrochloric Acid; Liver; Malondialdehyde; Oxidative Stress; Rats; Vascular Endothelial Growth Factor A | 2014 |
Activation of α2 adrenoceptor attenuates lipopolysaccharide-induced hepatic injury.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Alanine Transaminase; Animals; Aspartate Aminotransferases; Biomarkers; Chemical and Drug Induced Liver Injury; Cytoprotection; Dexmedetomidine; Disease Models, Animal; Interleukin-1beta; Interleukin-6; Lactic Acid; Lipopolysaccharides; Liver; Male; Malondialdehyde; Oxidative Stress; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-2; Sepsis; Superoxide Dismutase; Time Factors; Tumor Necrosis Factor-alpha; Yohimbine | 2015 |
Vitamin C ameliorates high dose Dexmedetomidine induced liver injury.
Topics: Animals; Ascorbic Acid; Chemical and Drug Induced Liver Injury; Dexmedetomidine; Oxidative Stress; Protective Agents; Rats; Rats, Wistar | 2016 |